š¬ Current Disease Focus:
Task Progress: 0%
š„ Active Problem Solvers
0
š Experts collaborating globally
ā” Current Task Assignment
š§¬ Genetic Analysis
š Matching experts to specific tasks
š Resource Allocation by Research Phase:
š Data Analysis
š§Ŗ Experimental Design
š¬ Clinical Trials
š Treatment Development
This study is to determine the safety and recommended dosing of Minnelide i...
Status
Terminated
Location
H. Lee Moffitt Cancer Center and Research Institute
Start Date
2019-04-18
Trial ID
NCT03760523
Treatments Being Tested
The primary objective of this study is to determine the maximum tolerated d...
Status
Completed
Location
Virginia G. Piper Cancer Center at Scottsdale Healthcare
Start Date
2013-08
Trial ID
NCT01927965
Treatments Being Tested
MinPAC aims to see if the drug Minnelide can slow down tumour growth in pat...
Status
Completed
Location
HonorHealth Research Institute
Start Date
2017-04-10
Trial ID
NCT03117920
Treatments Being Tested
A Phase 1b, Open-Label, Safety, Pharmacokinetic, and Pharmacodynamic Study ...
Status
Unknown
Location
Samsung Medical Center
Start Date
2022-11-01
Trial ID
NCT05557851
Treatments Being Tested
A Phase 1, Open-label, Dose-Escalation, Safety, Pharmacokinetic and Pharmac...
Status
Unknown
Location
Samsung Medical Center
Start Date
2020-11-02
Trial ID
NCT05566834
Treatments Being Tested
A Phase I, Multicenter, Open-label, Dose-Escalation, Safety, Pharmacokineti...
Status
Unknown
Location
University of Alabama at Birmingham
Start Date
2017-10-10
Trial ID
NCT03129139
Treatments Being Tested
Background: Pancreatic cancer is one of the most lethal types of cancer. A...
Status
Completed
Location
National Institutes of Health Clinical Center
Start Date
2022-03-07
Trial ID
NCT04896073
Treatments Being Tested
This phase Ib trial tests the side effects and best dose of minnelide when ...
Status
Active Not Recruiting
Location
City of Hope Medical Center
Start Date
2022-03-07
Trial ID
NCT05166616
Treatments Being Tested
Minnelide, a water-soluble disodium salt variant of triptolide, is a diterp...
Status
Withdrawn
Location
Multiple Locations
Start Date
2018-04
Trial ID
NCT03347994
Treatments Being Tested